Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the ...

Guggenheim analyst Michael Schmidt raised the firm’s price target on Exelixis (EXEL) to $42 from $33 and keeps a Buy rating on the shares.

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care LONDON, Jan. 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...

Zanzalintinib stands out as Exelixis’ most clinically advanced asset with potential to become a primary contributor in the medium to long term, says the analyst, who is incorporating zanza into ...

Here are some of the drugs that are predicted to become blockbusters in the next few years, according to Clarivate's latest ...

Drugs for metabolic diseases, vaccines and cancer therapies feature among new product launches this year that could top $1 ...

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn ...

Ukraine's air force says one of its F-16 fighter jet pilots shot down six missiles during a Russian aerial attack last month. Meanwhile, Moscow says its troops have inflicted a series of defeats ...

Scientists consider the Lord Howe Island stick insect, often called the "tree lobster," the world’s rarest insect. It was thought extinct after black rats coming ashore from the SS Makambo in 1918 ...

Delhi Elections 2025: One-Phase Polling Likely, Voting on 6th February, Counting on 8th February Delhi Elections: Ramvir Singh Bidhuri Makes Bold Claim Ahead of Election Announcement ...